FDA Approves PERSERIS — Indivior Inc.

FDA approval of Indivior Inc.'s PERSERIS, a risperidone implant, expands the company's market footprint within the long-acting antipsychotic sector, introducing a strategic alternative to oral formulations that is expected to impact the competitive landscape.